Recombinant human tumor necrosis factor depresses serum iron in mice
- PMID: 3681344
Recombinant human tumor necrosis factor depresses serum iron in mice
Abstract
Recently many findings about the physiological and biochemical functions of recombinant human tumor necrosis factor (rHu-TNF) have been reported. In the present study, the effect of rHu-TNF on serum iron in C3H/HeN and C57BL/6 mice was determined. Blood samples were obtained before intravenous injection of rHu-TNF, and also at various times after the injection. Results from five experiments showed that the serum iron was depressed between 1/3 to 1/5 of that of untreated mice 4 to 24 h after injection of 5 or 10 micrograms of rHu-TNF. The low level persisted for 33 h, rebounded at 48 to 72 h, and returned to normal by 96 h after the injection. Serum iron was determined by the colorimetric method using the sensitive reagent, ferrozine (3-(2-pyridyl)-5,6-bis(4-sulfophenyl)-1,2,4-triazine. We believe that this is the first report of depression of serum iron in mice by intravenous injection of rHu-TNF. The physiological role of repressed serum iron in the in vivo response to TNF remains to be established.
Similar articles
-
Recombinant human tumor necrosis factor causes long-lasting and prostaglandin-mediated fever, with little tolerance, in rabbits.J Pharmacol Exp Ther. 1988 Apr;245(1):336-41. J Pharmacol Exp Ther. 1988. PMID: 3162987
-
Tumor necrosis factor depresses gut absorptive function.Circ Shock. 1993 Apr;39(4):279-84. Circ Shock. 1993. PMID: 8485819
-
Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor.Lab Invest. 1989 Sep;61(3):319-22. Lab Invest. 1989. PMID: 2788773
-
Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation.J Lab Clin Med. 1994 Dec;124(6):813-20. J Lab Clin Med. 1994. PMID: 7798795
-
Tumor necrosis factor-alpha potentiates RhoA-mediated monocyte transmigratory activity in vivo at a picomolar level.Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2138-45. doi: 10.1161/ATVBAHA.109.195735. Epub 2009 Sep 10. Arterioscler Thromb Vasc Biol. 2009. PMID: 19745197
Cited by
-
Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.Clin Chim Acta. 2010 Sep 6;411(17-18):1248-52. doi: 10.1016/j.cca.2010.04.031. Epub 2010 May 10. Clin Chim Acta. 2010. PMID: 20460119 Free PMC article.
-
Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes.J Clin Invest. 1997 May 15;99(10):2518-29. doi: 10.1172/JCI119436. J Clin Invest. 1997. PMID: 9153296 Free PMC article.
-
Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice.Biochem J. 2006 Jul 1;397(1):61-7. doi: 10.1042/BJ20060215. Biochem J. 2006. PMID: 16566752 Free PMC article.
-
Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma.J Clin Invest. 1993 Mar;91(3):969-76. doi: 10.1172/JCI116318. J Clin Invest. 1993. PMID: 8450071 Free PMC article.
-
Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo.Br J Exp Pathol. 1989 Dec;70(6):697-704. Br J Exp Pathol. 1989. PMID: 2690922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous